Through years of research and advocacy, Peter Stock, a transplant surgeon at UCSF, helped clear the way for California’s first organ transplants from an HIV-positive donor to HIV-positive recipients.

By piercing liver cells with rapid pulses of electricity, scientists at UC San Francisco have demonstrated an entirely new way to transplant cells into organs to treat disease.

Using video microscopy in the living mouse lung, UC San Francisco scientists have revealed that the lungs play a previously unrecognized role in blood production.

Two UCSF faculty members – a microbiologist who studies the genesis of asthma and a surgeon who helped lift the ban on organ transplants between HIV-positive donors and recipients – are among this year’s 100 Leading Global Thinkers selected by Foreign Policy magazine.

Researchers at UCSF and the academically affiliated Gladstone Institutes have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection.

Chronic pain and loss of bladder control are among the most devastating consequences of spinal cord injury.

A team of researchers led by UCSF scientists has demonstrated in mice that it is possible to generate healthy new liver cells within the organ itself, making engraftment unnecessary.

For the first time, an immunosuppressive agent has shown better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care, according to a worldwide study led by UC San Francisco and Emory University investigators.